|Mergers and Acquisitions
||[Jun. 12th, 2008|04:12 pm]
What's in the Autoclave? A Blog about Science
Today's New York Times business section reports on the just-announced purchase of Applied Biosystems by Invitrogen. These two companies are big names in the American scientific supplies and tools world. Applied Biosystems is probably best-known for making equipment including machines that perform "real time PCR," a sensitive and quantitative method of measuring gene expression that has become widely used in many subfields of biology over the last decade. Invitrogen is one of the largest suppliers of biomedical research supplies in a wide array of areas, particularly relating to genetics and in vitro cell culture. Their purchase in 2000 of rival Gibco (a major supplier of in vitro tissue culture reagents) ensured that pretty much every US cellular or molecular biology research lab is using at least some of their products.|
Mergers are always a little bit worrysome; competition among vendors for our research dollars helps keep costs down across the board. But I'm not an economist, so I probably shouldn't speculate too much on the impact of this merger. Invitrogen, as far as I know, doesn't currently produce instrumentation for real-time PCR, although both companies sell the consumables required to use the machines. There are other providers of all of these products, including Stratagene, so there won't be an absolute monopoly.
A press release on the acquisition is found on the ABI website, here.